SuperworthHumana Inc. HUM
Medical - Healthcare Plans, Healthcare
$386.59
−2.50%
- Market cap
- $46.4B
- PE
- 37.5×
- 10y median 20.5×
- Forward PE
- Price to sales
- 0.3×
- EV/EBIT
- 12.8×
- Revenue, 12 months
- $145.7B
- +18% on a year ago
- Net margin
- 0.9%
- Free cash flow yield
- 4.1%
Humana trades at 37.5× trailing earnings, pricier than 96% of the last ten years. Revenue was $145.7B over the last twelve months, up 18% on a year earlier with a 1% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $26.5B | $29.6B | $29.5B | $29.4B | $29.2B+10% | $32.1B+8% | $32.4B+10% | $32.6B+11% | $32.5B+11% | $39.6B+24% | $40.9B+26% | |
| Cost of revenue | $22.8B | $25.1B | $25B | $25.1B | $25.4B+11% | $26.5B+6% | $27.6B+10% | $28B+11% | $28.7B+13% | $33.7B+27% | $35.4B+28% |
| Gross profit | $3.7B | $4.5B | $4.5B | $4.3B | $3.8B+4% | $5.6B+24% | $4.8B+7% | $4.7B+9% | $3.8B−1% | $5.9B+7% | $5.5B+14% |
| SG&A | $3.8B | $3B | $3.1B | $3.3B | $4.2B+9% | $3.4B+11% | $3.5B+13% | $4.1B+22% | $4.4B+7% | $4B+19% | $4B+12% |
| −$348M | $1.2B | $1.1B | $728M | −$543M+56% | $2B+63% | $1.1B−4% | $400M−45% | −$808M+49% | $1.8B−13% | $1.4B+24% | |
| Interest expense | $146M | $159M | $168M | $169M | $164M+12% | $160M+1% | $157M−7% | $168M−1% | $146M−11% | $193M+21% | $197M+26% |
| Pre-tax income | −$610M | $990M | $901M | $635M | −$899M+47% | $1.7B+71% | $741M−18% | $134M−79% | −$1B+14% | $1.6B−6% | $952M+29% |
| −$75M | $251M | $223M | $155M | −$216M+188% | $406M+62% | $179M−20% | −$86M | −$249M+15% | $395M−3% | $238M+33% | |
| Net income | −$541M | $741M | $679M | $480M | −$693M+28% | $1.2B+68% | $545M−20% | $195M−59% | −$796M+15% | $1.2B−5% | $694M+27% |
| −$4.42 | $6.11 | $5.62 | $3.98 | −$5.76+30% | $10.30+69% | $4.51−20% | $1.62−59% | −$6.61+15% | $9.83−5% | $5.73+27% | |
| 122.5M | 121.3M | 120.7M | 120.8M | 120.8M−1% | 120.8M−0% | 120.7M+0% | 120.7M+0% | 120.3M−0% | 120.7M−0% | 121.1M+0% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Medical - Healthcare Plans within ten times Humana's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| HUMHumana Inc. | $46.4B | 37.5× | 20.5× | 0.3× | +18% | 0.9% | |
| CICigna Corporation | $74.1B | 11.5× | 16.1× | 0.3× | +8% | 2.3% | |
| ELVElevance Health Inc. | $87.6B | 18.0× | 17.6× | 0.4× | +6% | 2.5% | |
| CVSCVS Health Corp. | $112.8B | 23.3× | 16.2× | 0.3× | +7% | 1.2% | |
| UNHUnitedHealth Group Incorporated | $334.3B | 24.2× | 22.4× | 0.7× | +6% | 3.1% | |
| Peer median | $100.2B | 20.6× | 16.9× | 0.4× | +7% | 2.4% |
About
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .